Legislation Sparks Hope for Enhanced Medication Safety and Transparency
(Minnesota) – February 5th, 2024- – In a positive development for individuals with allergies, legislators are considering the ADINA Act, a groundbreaking initiative led by Representative Dean Phillips. The ADINA Act is a bill that would amend the Food, Drug, and Cosmetic Act to require labeling of major food allergens or gluten-containing grains on drugs intended for human use and hold medications to the same labeling standards as food products.